Bicarbonate for In-Hospital Cardiac Arrest

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 778 participants.

Also called NCT05564130

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 778 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05564130
Other papers using this trial's data
  • Sodium Bicarbonate for In-Hospital Cardiac Arrest: A Randomized Clinical Trial JAMA, 2026-08-25 DOI, PubMed 42273960, PMC13261510 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05564130. Randomized; quadruple masking; primary purpose treatment. Start 2023-02-06 (actual); primary completion 2026-02-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bicarbonate for In-Hospital Cardiac Arrest
Acronym
BIHCA
Intervention (Drug)
Sodium bicarbonate
Intervention (Drug)
Sodium chloride
Lead sponsor
Lars Wiuff Andersen (class: other)
Collaborator
University of Aarhus (class: other)

Record details

Record id
cardio:ct-nct05564130
Content hash
04fd15d69e893ac91edb4e65a0a4715b397d00185597b29a920570c133c2ae03